Windham Venture Partners
Windham Venture Partners is a New York City based venture capital firm investing in healthcare companies with a focus on medical technology and digital health.
All edits
Edits on 12 Apr, 2023
Golden AI
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 5 Oct, 2022
Golden AI
Edits on 24 Aug, 2022
Golden AI
Edits on 15 Aug, 2022
Golden AI
Edits on 28 Jul, 2022
Golden AI
Edits made to:
Article
Article
Windham Venture Partners has made investments in NovellusDx, MC10, Nebula Genomics, Earlens Corporation, Nuvaira, NeuSpera Medical, CVRx, CredSimple, SubjectWell, Science Exchange, Blueprint Health, Cartiva, Coravin and Cureatr.
Windham Venture Partners has exited investments in Transactis, Neotract and Cartiva.
Edits on 26 May, 2022
Vlad Botushninu
Edits on 21 May, 2022
Ирина Носкова
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 17 May, 2022
Katrina-Kay Pettitt
Edits on 5 Apr, 2022
Katrina-Kay Pettitt
Edits on 28 Mar, 2022
Golden AI
Edits on 4 Feb, 2022
Bhupendra Solanki
Edits made to:
Infobox (+1 properties)
Edits on 12 Apr, 2021
Neelam Jhaveri
Edits made to:
Article (+11/-11 characters)
Article
Windham Venture Partners has made investments in NovellusDx, MC10, Nebula Genomics, Earlens Corporation, Nuvaira, NeuSpera Medical, CVRx, CredSimple, SubjectWellSubjectWell, Science Exchange, Blueprint Health, Cartiva, Coravin and Cureatr.
Edits on 29 Mar, 2021
Golden AI
Golden AI
Golden AI
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Invested in
Find more companies like Windham Venture Partners
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.